From:  Real-life effectiveness of mepolizumab on remission and chronic rhinosinusitis with nasal polyps in severe eosinophilic asthma

 Asthma control assessment.

Evaluation aspectsClinical description (past 4 weeks)Score definition (1–5)
Activity limitationThe extent to which asthma interfered with work, school, or home activities.1 = All of the time
2 = Most of the time
3 = Some of the time
4 = A little of the time
5 = None of the time
Shortness of breathFrequency of shortness of breath episodes.1 = More than once a day
2 = Once a day
3 = 3–6 times a week
4 = Once or twice a week
5 = Not at all
Nocturnal symptomsFrequency of being awakened at night or early morning due to asthma symptoms (wheezing, coughing, chest tightness, shortness of breath).1 = 4 or more nights a week
2 = 2–3 nights a week
3 = Once a week
4 = Once or twice
5 = Not at all
Rescue medication useFrequency of rescue inhaler or nebulizer use (e.g., albuterol).1 = 3 or more times per day
2 = 1–2 times per day
3 = 2–3 times per week
4 = Once a week
5 = Not at all
Overall asthma controlPatient’s self-assessment of asthma control.1 = Not controlled at all
2 = Poorly controlled
3 = Somewhat controlled
4 = Well controlled
5 = Completely controlled
Return to article view

Evaluation: sum the scores for all questions (25–20: well-controlled; 19–15: partial control; < 15: poorly controlled).